Home Applications 125388 Application 125388
Type BLA
Sponsor SEATTLE GENETICS Purple Book Biologic Products# BLA, Proprietary name, Proper name table BLA Proprietary name Proper name License type Status Latest source 125388 Adcetris brentuximab vedotin 351(a) Rx 2026-06-01
Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 ADCETRIS BRENTUXIMAB VEDOTIN INJECTABLE; INJECTION 50MG/VIAL No No
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
NDC Listings For This Application# NDC listings for this application page 1 of 1 · 6 matching rows.
NDC, Name, Nonproprietary name table NDC Name Nonproprietary name Labeler Marketing category Status 51144-050 ADCETRIS brentuximab vedotin SEAGEN INC. BLA Current 51144-050 ADCETRIS brentuximab vedotin Seattle Genetics, Inc. BLA Current 51144-050 ADCETRIS brentuximab vedotin Seattle Genetics, Inc. BLA Current 51144-050 ADCETRIS brentuximab vedotin SEAGEN INC. BLA Current 51144-050 ADCETRIS brentuximab vedotin SEAGEN INC. BLA Current 51144-050 ADCETRIS brentuximab vedotin SEAGEN INC. BLA Current